Initiator Pharma A/S (INIT.ST)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Dr. Claus Elsborg Olesen | Co-Founder, CEO & Director | 1.13M | -- | 1974 |
| Dr. Dan Peters Ph.D. | Co-Founder & CTO | -- | -- | 1961 |
| Prof. Ulf Simonsen Ph.D. | Co-Founder, CMO & CSO | -- | -- | 1963 |
| Dr. Mikael Thomsen M.Sc., Ph.D. | Co-Founder & Chief Development Officer | -- | -- | 1968 |
| Dr. Torgeir Vaage Ph.D. | Chief Financial Officer | -- | -- | 1964 |
| Dr. Allan Wehnert | Senior Vice President of Clinical and R&D Strategy & Portfolio Management | -- | -- | -- |
| Susanne Thomsen | Head of Clin Ops | -- | -- | -- |
| Mr. Rene Egebro M.Sc. | Head of CMC | -- | -- | -- |
Initiator Pharma A/S
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 1
Description
Initiator Pharma A/S, a clinical stage life science company, develops drugs targeting unmet medical needs within the central and peripheral nervous system. Its product pipeline includes IPED2015, a drug candidate which is in clinical phase 2a for the treatment of organic erectile dysfunction; IP2018, a monoamine reuptake inhibitor completed Phase IIa for the treatment of psychogenic erectile dysfunction primarily targeting the serotonin followed by the dopamine system; and IPTN2021, a Phase 1 clinical drug program targeting an orphan drug indication in severe neuropathic pain, and trigeminal neuralgia. The company also developing IP2017, a proprietary triple reuptake inhibitor; and IP2016, a preclinical development for the treatment of depression. Initiator Pharma A/S was incorporated in 2016 and is headquartered in Copenhagen, Denmark.
Corporate Governance
Upcoming Events
May 9, 2025 at 10:59 AM UTC
Initiator Pharma A/S Earnings Date
Recent Events
Recent Events Information Not Available